Mish's Global Economic Trend Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The Vet who wrote (100429)	8/6/2009 9:32:31 AM
From: Oblomov	Read Replies (3) of 116555

>>In the US every big pharma company spends more on advertising and lobbying than they do on research... Not true in the case of most pharma companies. Certainly it is true in the case of the generic manufacturers. Branded pharma manufacturers spend more on meeting regulatory requirements (of which over half is spent on Phase 3 trials) than they do on clinical research or marketing. The regulatory agencies should be empowered with ensuring safety only. There have been some failures in this basic function, so it should be the FDA's sole focus. We should let the doctor use third party research to make decisions about efficacy. The result would be more widely available and much cheaper drugs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next